| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 11/24/2005 | US20050261203 Azabicyclo-octane inhibitors of IAP |
| 11/24/2005 | US20050261196 Comprising nonapeptide wherein first three amino acids and last three amino acids of sequence comprise basic amino acids, and wherein inhibitor comprises at least one D-amino acid or at least one non-hydrolyzable bond; may be used to treat intestinal diseases; infectious, ischemic, inflammatory disease |
| 11/24/2005 | US20050261193 Antimicrobial theta defensins and methods of using same |
| 11/24/2005 | US20050261192 Novel polypeptide and its DNA |
| 11/24/2005 | US20050261190 Fas associated factor 1 |
| 11/24/2005 | US20050261189 Methods of promoting cardiac cell proliferation |
| 11/24/2005 | US20050261188 Genes encoding proteins with pesticidal activity |
| 11/24/2005 | US20050261186 NRG-2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
| 11/24/2005 | US20050261183 PTHrP-derived modulators of smooth muscle proliferation |
| 11/24/2005 | US20050261175 monoclonal antibody immunoreactive with a stem cell factor; hybridoma cell line; can stimulate growth of primitive progenitors including early hematopoietic progenitor cells |
| 11/24/2005 | US20050261172 Peptide for increasing bone density; peptide is glycosylated, is 4 amino acids in length; the amino acid sequence consists of a sequence identical to the first 4 consecutive amino acids |
| 11/24/2005 | US20050261170 Folate conjugates and complexes |
| 11/24/2005 | US20050261169 Peptide and peptide mimetic derivatives having integrin inhibitor properties III |
| 11/24/2005 | US20050261166 Compositions and methods for the therapy and diagnosis of lung cancer |
| 11/24/2005 | US20050260758 High efficiency peptide production in plant cells |
| 11/24/2005 | US20050260746 Transgenic pig containing heat shock protein 70 transgene |
| 11/24/2005 | US20050260739 Comprising a disrupted ACR3 gene; treating waste water containing heavy metal ion such as As; pollution control |
| 11/24/2005 | US20050260734 Packaging cells |
| 11/24/2005 | US20050260732 Polypeptide crystal having a polyhistidine tag added to the C-terminal end; effectors; drug screening for enzyme inhibitors; multiple sclerosis, diabetes, Grave's disease, rheumatic arthritis, AIDS, cancer, immunomodulators |
| 11/24/2005 | US20050260731 Lipoprotein associated phospholipase A2, inhibitors thereof and use of the same in diagnosis and therapy |
| 11/24/2005 | US20050260730 CDK2/cyclin A crystals and uses thereof |
| 11/24/2005 | US20050260726 Novel human protease inhibitor and polynucleotides encoding the same |
| 11/24/2005 | US20050260717 Double transdominant fusion gene and protein |
| 11/24/2005 | US20050260716 Non-immunoglobulin polypeptide, linker and dimerizing domain; cell-surface receptors; signal transduction |
| 11/24/2005 | US20050260715 Efficient methods for producing antimicrobial cationic peptides in host cells |
| 11/24/2005 | US20050260714 Novel compounds |
| 11/24/2005 | US20050260713 Polypeptides and nucleic acids encoding same |
| 11/24/2005 | US20050260709 Lipin1 function |
| 11/24/2005 | US20050260708 Proteases and protease inhibitors |
| 11/24/2005 | US20050260707 Corynebacterium glutamicum genes encoding metabolic pathway proteins |
| 11/24/2005 | US20050260706 Silk biomaterials and methods of use thereof |
| 11/24/2005 | US20050260702 Novel integrin alpha subunit and uses thereof |
| 11/24/2005 | US20050260701 Method for enzymatic production of GLP-1 (7-36) amide peptides |
| 11/24/2005 | US20050260693 Tumor suppressor gene |
| 11/24/2005 | US20050260687 DNA encoding mammalian neuropeptide FF (NPFF) receptors and uses thereof |
| 11/24/2005 | US20050260682 Compositions and methods for diagnosing or treating psoriasis |
| 11/24/2005 | US20050260675 Useful in identifying and designing novel Bt toxin receptor ligands including novel insecticidal toxins; manipulating Bt toxin susceptibility in plant pests |
| 11/24/2005 | US20050260674 Specific polypeptides, useful as nematocides |
| 11/24/2005 | US20050260673 nematode-specific gene products that can serve as targets for inhibitory peptides and proteins (e.g., antibodies) and antiparasitic chemicals |
| 11/24/2005 | US20050260670 Novel receptor trem (triggering receptor expressed on myeloid cells) and uses thereof |
| 11/24/2005 | US20050260669 Antibodies to iron regulating protein -2 (IRP-2) as a diagnostic for neurodegenerative disease |
| 11/24/2005 | US20050260668 Novel compounds |
| 11/24/2005 | US20050260667 determining the predisposition of individuals to schizophrenia, bipolar disorder and mental disorders; drug screening; reduced side effects |
| 11/24/2005 | US20050260657 Molecular entity for controlling a calcium |
| 11/24/2005 | US20050260650 Alternatively spliced isoforms of interleukin-4 receptor subunit alpha (IL-4Ralpha) |
| 11/24/2005 | US20050260644 Cell signaling proteins |
| 11/24/2005 | US20050260643 Cancer specific promoters |
| 11/24/2005 | US20050260642 CNGH0011 polynucleotides, polypeptides, antibodies, and compositions, and methods of production and use |
| 11/24/2005 | US20050260634 Achaete-scute like-2 polypeptides and encoding nucleic acids and methods for the diagnosis and treatment of tumor |
| 11/24/2005 | US20050260632 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 11/24/2005 | US20050260622 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 11/24/2005 | US20050260621 Immunoreactive 38-KDA ferric binding protein of ehrlichia canis and uses thereof |
| 11/24/2005 | US20050260616 Nucleotide and protein sequences of Nogo genes and methods based thereon |
| 11/24/2005 | US20050260604 Antigens derived from the core protein of the human mammary epithelial mucin |
| 11/24/2005 | US20050260601 Recombinant mutants of rhabdovirus and methods of use thereof |
| 11/24/2005 | US20050260599 Nucleic acid and amino acid sequences of sweet taste receptors comprising two heterologous G-protein coupled receptor polypeptides; screening for modulators; probes for the identification of taste cells |
| 11/24/2005 | US20050260598 Novel clot-specific streptokinase proteins possessing altered plasminogen activation characteristics and a process for the preparation of said protein |
| 11/24/2005 | US20050260596 Packaging systems for human recombinant adenovirus to be used in gene therapy |
| 11/24/2005 | US20050260595 Screening for substances capable of regulating signal transduction from dopamine or adenosine receptor to adenylate cyclase; measuring effector activity or index value; Gm1 |
| 11/24/2005 | US20050260590 Yeast-origin promoter and vector and expression system using the same |
| 11/24/2005 | US20050260589 Synthase of cereulide produced by bacillus cereus, gene encoding the same and method of detecting cereulide |
| 11/24/2005 | US20050260587 Synthetic transfer complex and method for transferring nucleic acids |
| 11/24/2005 | US20050260582 Cell proliferation inhibitors comprising ets transcription factor or gene encoding the same |
| 11/24/2005 | US20050260581 Gonococcal proteins and nucleic acids |
| 11/24/2005 | US20050260579 TGF-beta type receptor cDNAs encoded products |
| 11/24/2005 | US20050260576 Recombinantly expressed and isolated human SCN1A polypeptide and a modified human SCN1A nucleic acid that encodes it; producing an antibody that specifically binds a sodium channel; detecting and/or identifying a sodium channel polypeptide; anticonvulsants, neuroprotective agents and analgesics |
| 11/24/2005 | US20050260571 Human serpin |
| 11/24/2005 | US20050260567 NS5A nucleotide sequence variation as a marker for interferon response |
| 11/24/2005 | US20050260565 contacting in vitro a sample comprising chemokine 88C receptor with a putative ligand, detecting binding of the 88C receptor and the putative ligand; increase in 88C signal transduction activity indicates the ligand is an activator, a decreasein transduction activity indicates the ligand is an inhibitor |
| 11/24/2005 | US20050260564 Non-cytotoxic oriP replicon |
| 11/24/2005 | US20050260559 Antiviral agent against picornavirus infections, the assayselects an agent that disrupts the association between picornavirus protein 2c and the host cell protein DAKAP2for viral replication |
| 11/24/2005 | US20050260292 Sovent extraction of hemagglutinin specific for acetyl-D-galactosamine residues of O-glycosidically linked oligosaccharide of glycophorin A by homogenizing seeds with a homogenizing agent comprising phosphate-buffered saline and glycine;centrifuging and filtering to collect supernatant; antitumor agent |
| 11/24/2005 | US20050260248 Collagenous tissue compositions |
| 11/24/2005 | US20050260235 Aids vaccines |
| 11/24/2005 | US20050260234 Anti-neovasculature preparations for cancer |
| 11/24/2005 | US20050260233 Attenuated vaccine useful for immunizations against Coccidioides spp. infections |
| 11/24/2005 | US20050260232 Attenuated Mycobacterium tuberculosis vaccines |
| 11/24/2005 | US20050260230 Leucine-based motifs and enhanced biological persistence of clostridial neurotoxins |
| 11/24/2005 | US20050260229 Glycans of Anaplasma marginale major surface protein 1a, pharmaceutical compositions and methods of use |
| 11/24/2005 | US20050260224 Vaccine based on a cellular penetration factor from an apicomplexan parasite |
| 11/24/2005 | US20050260223 Salmonella vaccine materials and methods |
| 11/24/2005 | US20050260222 Structure-based receptor MIMICS targeted against bacterial superantigen toxins |
| 11/24/2005 | US20050260221 Hepatitis C virus constructs characterized by high efficiency replication |
| 11/24/2005 | US20050260220 first component is the modified antigenic ectodomain of measles virus hemagglutinin protein, second component fused to first component that binds a surface protein of human immunodeficiency virus; for treating HIV infection and other therapeutic targets against which it is difficult to develop vaccines |
| 11/24/2005 | US20050260218 House dust mite allergen, Der f VII, and uses therefor |
| 11/24/2005 | US20050260216 Polypeptide containing a mutation characteristic of an analogous non-human protein; is capable of raising antibodies in human, antibodies bind to both the human protein and the polypeptide |
| 11/24/2005 | US20050260215 Conjugate between a modified superantigen and a target-seeking compound and the use of the conjugate |
| 11/24/2005 | US20050260209 Ephrin-b receptor protein involved in carcinoma |
| 11/24/2005 | US20050260203 Use of fusion polypeptides capable of binding vascular endothelial cell growth factor (VEGF), VEGF family members, and splice variants with specifically desirable characteristics; therapy for ocular diseases |
| 11/24/2005 | US20050260200 Antigenic peptides reacting with anti-ovary antibodies |
| 11/24/2005 | US20050260199 For inhibition of viral entry into cells; purified antibodies |
| 11/24/2005 | US20050260197 Receptor for Oncostatin M |
| 11/24/2005 | US20050260194 Immunoglobulin chimeric monomer-dimer hybrids |
| 11/24/2005 | US20050260192 Leukocyte function associated antigens comprising integrin I-domain for use in identifying modulators for prevention and treatment of inflammatory disorders; immunosuppressive agents |
| 11/24/2005 | US20050260191 for determining bioactive intact PTH levels in serum, plasma, and/or cell culture media; have a novel recognition for amino acid residues extending beyond the first N-terminal PTH residue; have binding affinity and specificity for PTH that have mitigated cross-reactivity to large non (1-84) PTH fragments |
| 11/24/2005 | US20050260182 obtained from endophytic Streptomycetes isolated from higher plants; biological activity against plant pathogensPythium ultimum, Phytophthora cinnamomi, Cryptococcus neoformans, Candida albicans; parasitic Plasmodium falciparum; bacterial pathogen, Streptococcus pneumoniae; breast epithelial cancer cell |
| 11/24/2005 | US20050260177 Compounds for immunotherapy and diagnosis of colon cancer and methods for their use |
| 11/24/2005 | US20050260166 Expressional enhancers from viruses |
| 11/24/2005 | US20050260162 Conditionally replicative adenovirus to target the Rb and Rb-related pathways |
| 11/24/2005 | US20050260159 contacting a collagenase-producing cell in a tissue with an intracellular IL-1 receptor antagonist peptide to inhibit tissue destruction, thus inhibiting inflammatory diseses e.g. rheumatoid arthritis, degenerative intervertebral disc disease and chronic skin ulcers; inhibitor of matrix metalloproteinase |